This inventor holds 2 USPTO granted patents. Top assignees: Keio University, Kochi University, National University Corporation Kochi University. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 361 
1 out of 50 
1 out of 3 Years Active: 2022-2026
Title: Kenji Morii: Innovator in Cancer Treatment
Introduction
Kenji Morii is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of new technologies. His work focuses on creating advanced therapeutic solutions for challenging medical conditions.
Latest Patents
Kenji Morii holds a patent for an "Anti-glypican-1-immunizing antigen receptor." The purpose of this invention is to produce a chimeric antigen receptor (CAR) that is specific to glypican-1 (GPC-1) and to treat squamous cell carcinoma using genetically modified cells capable of expressing the CAR. This invention provides a chimeric antigen receptor designed for the treatment and/or prevention of squamous cell carcinoma. It includes an extracellular domain that binds to GPC-1, a transmembrane domain, and one or multiple intracellular domains. At least one of these intracellular domains contains a primary cytosolic signaling sequence or both a primary and a secondary cytosolic signaling sequence. Additionally, it involves a genetically modified cell capable of expressing the chimeric antigen receptor and a cell preparation containing the cell.
Career Highlights
Throughout his career, Kenji Morii has worked with esteemed institutions such as Keio University and Kochi University. His research has focused on developing innovative solutions that address critical health challenges, particularly in oncology.
Collaborations
Kenji Morii has collaborated with notable colleagues, including Daiki Kato and Tetsuji Naka. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Kenji Morii is a dedicated inventor whose work in cancer treatment exemplifies the potential of innovative research in medicine. His contributions, particularly in the development of chimeric antigen receptors, are paving the way for new therapeutic approaches to combat squamous cell carcinoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile